Excelsus Offers Cutting Edgecustomizableand Cost Effective Synchrotron Based Structural Characterization Services For Pharmaceuticals At Every Stage Of Their Product Lifecycle Ae From Selection And Development To Manufacturingstability Studiesand Ip Protectionwith Excelsusyou Gain Access To Analyses Via Synchrotron X Ray Powder Diffraction Characterized By Exceptional Angular Resolution And Counting Statisticsenabling Ultra Low Levels Of Detection Of Crystalline Phases In Complex Drug Substances And Drug Productsadditionallyexcelsus Provides Innovative Methodologies Designed For The Accurate Quantification Of Complex Polymorphic Mixtures In Pharmaceutical Drug Substances And Drug Productsregardless Of Whether Valid Structure Models Are Available Founded In 2012 As A Spin Off Of The Renowned Paul Scherrer Institutepsiin Switzerlandexcelsus Operates Worldwideusing Several Synchrotron Facilitiessuch As Slsswitzerland Albaspain Desygermany Esrffrance And Max Ivsweden Its Headquarters Are Located At Park Innovaarea Major Innovation Center In Switzerlandin The Proximity To The Psi And Its Synchrotron Facilityin 2023Our Growing Team Established Some Laboratories On The Sankt Johann Campus In Basela City Which Has Become One Of The Leading Biopharma Hubs In Europeour Access To State Of The Art Facilities And Extensive Know How Of X Ray Powder Diffraction Enable Us To Detect And Quantify Polymorphs As Low As 0 01Wt In Pharmaceutical Productsae Setting New Standards For Structural Characterization And Quality Control At Excelsuswe Go Beyond Lab Solutionsoffering Synchrotron Services With Superior Performance And Precision As An Affordable Alternative To Traditional Diffractometersfrom Structure Resolution And Polymorph Analysis To R&D Collaborationswe Advance Pharmaceutical Characterization With Unrivaled X Ray Diffraction Solutions Let S Work Together To Bring Your Products To The Next Level
